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Abstract     
Disrupted-In-Schizophrenia-1 (DISC1) is one of major susceptibility factors for a wide range of 
mental illnesses, including schizophrenia, bipolar disorder, major depression, and autism 
spectrum conditions.  DISC1 is located in several subcellular domains, such as the centrosome 
and the nucleus, and interacts with various proteins, including NudE-like (NUDEL/NDEL1) and 
activating transcription factor 4 (ATF4)/CREB2.  Nevertheless, a role for DISC1 in vivo remains 
to be elucidated.  Therefore, we have generated a Drosophila model for examining normal 
functions of DISC1 in living organisms.  DISC1 transgenic flies with preferential accumulation 
of exogenous human DISC1 in the nucleus display disturbance in sleep homeostasis, which has 
been reportedly associated with CREB signaling/CRE-mediated gene transcription.  Thus, in 
mammalian cells, we characterized nuclear DISC1, and identified a subset of nuclear DISC1 that 
co-localizes with the promyelocytic leukemia (PML) bodies, a nuclear compartment for gene 
transcription.  Furthermore, we identified three functional cis-elements that regulate the nuclear 
localization of DISC1.  We also report that DISC1 interacts with ATF4/CREB2 and a co-
repressor N-CoR, modulating CRE-mediated gene transcription. 
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Introduction  
Disrupted-In-Schizophrenia-1 (DISC1) is a promising genetic factor for a wide range of mental 
illnesses, including schizophrenia, bipolar disorder, major depression, and autism spectrum 
conditions (1-5).  Sleep disturbances, including deficits in sleep homeostasis and circadian 
rhythms, commonly accompany various types of psychiatric conditions (6, 7). 
     DISC1 protein has multiple functions and is located in several distinct domains in cells, 
including the centrosome, the postsynaptic density, the mitochondria, and the nucleus (8-11).  
DISC1 has specific protein interactors, corresponding to each subcellular domain, such as NudE-
like (NUDEL/NDEL1) at the centrosome and activating transcription factor 4 (ATF4)/CREB2 in 
the nucleus (11, 12).  We previously reported that a form of DISC1 enriched in the nucleus was 
increased in patients with sporadic schizophrenia and major depression as well as substance and 
alcohol abuse, suggesting that nuclear DISC1 may play a role in the pathophysiology of mental 
disorders (13).  Understanding the mechanisms underlying DISC1 function in brains in vivo, 
however, remains to be elucidated.   
     The fruit fly, Drosophila melanogaster, has been used as an excellent invertebrate model to 
explore molecular functions in brains in vivo (14-17).  Generation of genetically-engineered flies 
is much easier than generation of knockout or transgenic mice.  Thus, transgenic flies expressing 
human disease genes have been generated to examine functions of such disease factors, with the 
hope that these flies can be utilized as disease models (14-19).  Furthermore, a large number of 
genes for the biological processes or even specific factors that either enhance or suppress the 
phenotypes caused by expression of human disease genes can be screened.  In many cases, such 
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factors have been found to interact with disease proteins and form pathological pathways.  Thus, 
even if disease genes by themselves are not conserved between humans and flies, the disease 
gene-associated phenotypes in transgenic flies have been utilized to explore unknown biological 
processes that are conserved between flies and humans: one successful example is shown by 
transgenic flies expressing α-synuclein (18, 19).  Although there is no orthologue of α-synuclein 
in flies, the fly model exhibited adult-onset loss of specific sets of dopaminergic neurons, similar 
to human Parkinson’s disease, and helped to identify factors that can regulate the process, 
including Hsp 70 (19), which was later confirmed as a modified factor or genetic risk factor for 
Parkinson’s disease (20).   
     In the present study, we have generated and initially characterized a fly model expressing 
human DISC1.  The transgenic flies with a punctate accumulation of exogenous human DISC1 
in the nucleus display disturbance in sleep homeostasis, which has been reportedly associated 
with CREB signaling or CRE-mediated gene transcription (21).  Such punctate localization of 
DISC1 in the nucleus is also observed in mammalian cells with co-localization with 
promyelocytic leukemia (PML) bodies, a nuclear compartment for gene transcription.  We also 
identified three functional cis-elements that regulate nuclear localization of DISC1.  Reporter 
analyses, combined with interaction assays, support the notion that DISC1 modulates CRE-
mediated gene transcription by interacting with ATF4/CREB2 and recruiting a co-repressor N-
CoR to the transcriptional machinery.   
 6
Materials and Methods  
Constructs and antibodies   
Various DISC1 constructs were prepared in the pRK5 vector containing an N-terminal HA-tag.  
Mutations of DISC1 were introduced by PCR-based mutagenesis (22).  Constructs for fusion 
proteins of the C-terminus of enhanced green fluorescent protein (eGFP) with putative nuclear 
localization signal (NLS) and nuclear export signal (NES) were generated by subcloning with 
peGFP-C1 (Clontech, Mountain View, CA).  Rabbit polyclonal antibody against human DISC1 
was prepared as described (23).  The following mouse monoclonal antibodies were used: anti-
coilin antibody (Sigma, St. Louis, MO); anti-PML body antibodies (Santa Cruz Biotechnology, 
Santa Cruz, CA); anti-SC35 antibody (BD Pharmingen, San Diego, CA); and antibodies against 
HA-tag (Covance, Berkeley, CA).  The following rabbit polyclonal antibodies were used: anti-
CREB2 antibody (Santa Cruz); anti-mouse DISC1 antibody (Zymed, South San Francisco, CA); 
anti-N-CoR antibody (Upstate, Lake Placid, NY); and anti-FLAG antibody (Sigma).  Mouse 
anti-Fasciclin II (FAS II) (mAB1D4) and anti-Dachshund (DAC) (mABdac2-3) antibodies were 
from Developmental Studies Hybridoma Bank (University of Iowa, IA).  
 
Fly stocks 
Canton S (CS) and a white (w) stock outcrossed with Canton S at ten times (CS10) were used as 
the standard.  OK107 is a Gal4 enhancer trap line for the upstream regulatory modules of the 
eyeless/Pax6 gene, which is expressed in the majority of the MB neurons (24).  Flies carrying 
UAS-DISC1 transgene with an HA-tag were generated by P-element-mediated transformation 
and outcrossed to w(CS10) at least five times before behavioral assays.  Stocks were kept at 
 7
25 °C in 12 h light and 12 h dark conditions and were fed a standard diet consisting of 5.5 g agar, 
40 g yeast extract, 90 g cornmeal, and 100 g glucose per liter.   
 
Sleep assays 
Flies 3-6 days old were placed individually in 65 mm x 5 mm glass tubes plugged at one end 
with 5% sucrose and 2% agarose gel with or without 250 µM RU486.  Significant induction of 
Gal4 activity was confirmed with UAS-mCD8::GFP and anti-DISC1 staining.  No significant 
alteration of sleep amount was detected for the standard stocks at 250 µM RU486.   Fly activity 
was monitored with the Drosophila Activity Monitor System (Trikinetics, Waltham MA) at 25 °C 
in 12 h light and 12 h dark conditions as described (25).  The fly was confined in 5 mm length by 
moving the cotton plug into the tube.  Sleep was measured as a resting state longer than 5 min.  
To ensure protein induction and fly adaptation, the fly was placed in the monitor tube 48 h before 
starting data collection.   
 
Walk assay 
Flies were briefly sedated with CO2 and individually placed in 35-mm diameter plastic plates.  
After 1 h for recovery, walk behavior was monitored with a digital video camera for 2 min at 
25 °C under normal light condition.  To avoid fluctuation by circadian changes, all the recordings 
were done at the end of day when flies exhibit typical peak activity.  Walk behavior was analyzed 
based on the digital images of the walk tracks of the flies, and various parameters were analyzed 
using the Dynamic Image Analysis System (DIAS 3.0, Soll Technologies, IA). 
 
Immunofluorescent staining of fly tissues and mammalian cells   
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Drosophila brains were dissected and processed for staining as described (24, 26).  Mouse anti-
DAC and anti-FAS II were used at dilution 1:20 and 1:5, respectively.  TO-PRO3 (Invitrogen, 
Carlsbad, CA) was used at dilution 1:200.  Confocal images were taken with a Zeiss LSM510.  
HeLa cells were cultured in Dulbecco’s modified medium as recommended by the manufacturer.  
About 20 h after transfection by use of PolyFect (Qiagen, Valencia, CA), cells were fixed with 
4% paraformaldehyde (PFA) at 37 °C for 30 min.  Coverslips were mounted with PermaFluor 
(Thermo electon corporation).  Primary neuron cultures were prepared as described previously 
(11).  Experimental details for cell staining were as described (27).  Rabbit anti-mouse DISC1 
antibody (Zymed) was used at 1: 50 for primary neurons.  Cell staining was examined with a 
confocal microscope.  Each experiment was repeated at least three times. 
 
Cellular assays for DISC1 nuclear targeting 
Cellular distribution of the C-terminus of eGFP containing putative NLS or NES was monitored 
by GFP fluorescence under a confocal microscope 12 to 16 h after transfection.  HeLa cells with 
exogenously expressed HA-tagged DISC1 (wild-type, and mutants with key amino acid 
substitutions in the critical domains) were also examined by immunofluorescent cell staining 
with an anti-HA antibody, as described above.  Over 100 cells were examined under each 
condition with three independent transfections.   
 
Transcriptional assays  
Various expression constructs were co-transfected with either Gal4 or CRE reporter construct 
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into HeLa or IMR32 cells.  IMR32 cells were cultured in the MEM medium with 10% FBS.  One 
to 2 days after transfection, cells were suspended in the buffer provided in the kit for 
measurement of the luciferase activity (Luciferase Assay System (Promega, Madison, WI)) and 
normalized to ß-galactosidase activity or total protein amount.  Data are given as relative 
activities to the activity with Gal4 only, or that with ATF4/CREB2 only.  
 
In vitro binding assay 
Glutathione-S-transferase (GST) or GST-DISC1 protein was co-incubated with His-tagged 
ATF4/CREB2 at 4 °C for 2 h in 1 ml of binding buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 
0.2 mg/ml BSA).  Then, 20 μl of 50% glutathione-Sepharose beads were added to the mixture 
and incubated at 4 °C for 1 h.  The beads were washed four times with 1 ml of washing buffer 
(50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1 mg/ml BSA, 0.1% CHAPS), separated by SDS-
PAGE, and analyzed by Western blotting. 
 
Immunoprecipitation 
HeLa cells expressing HA-tagged DISC1 (wild-type or deletion mutant) together with 
ATF4/CREB2, or N-CoR, or fly CRC were lysed in RIPA buffer (150 mM NaCl, 50 mM Tris-
HCl, pH 7.5, 1% Nonidet P-40, 0.1% SDS, 0.5% sodium deoxycholate) containing a protease 
inhibitor mixture (Roche Applied Sciences, Indianapolis, IN), and the soluble proteins were 
subjected to immunoprecipitation by using either an anti-ATF4/CREB2 or an anti-N-CoR 
antibody, as described previously (13). 
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Statistical analysis 
All data were analyzed with Student’s t-test and Mann-Whitney U-test.  ** P <0.01. 
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Results 
Generation of transgenic flies expressing human DISC1 
Like the successful cases of α-synuclein transgenic flies, in which human transgenes with no fly 
orthologues are expressed (18, 19), there is no DISC1 orthologue in flies (28).  Nevertheless, 
many DISC1 interactors are conserved between humans and flies, including ATF4/CREB2 and 
NUDEL/NDEL1.  Therefore, we sought to determine whether generation of transgenic flies 
expressing human DISC1 would be useful in exploring the in vivo function of DISC1 in 
association with its protein interactors. 
     To express DISC1 in Drosophila brain, we utilized the GAL4-based GeneSwitch system, 
which allows inducible transgene expression in a temporally- and spatially-regulated manner by 
the addition of RU486 (29).  As shown in Supplementary Figure 1, DISC1 transgenic flies in the 
conventional expression system display no robust morphological changes in the mushroom 
bodies (MBs) in adults.  Nonetheless, in order to avoid any undetectable, but functionally critical, 
developmental impact due to constitutive expression of DISC1, we used GeneSwitch rather than 
conventional GAL4/UAS system to test functions of DISC1 in adult neurons.  We induced 
DISC1 expression in the MBs that play pivotal roles in cognition, associative learning, attention, 
and sleep control in flies (Figure 1A) (30-33).  Selective expression of a transgene in MB in this 
expression system was confirmed by the confocal assessment of adult fly brains expressing a 
reporter protein (Figure 1B, C).  In the present study, we first generated two types of transgenic 
flies, those expressing full-length human DISC1 (DISC1-FL) and those expressing a C-terminal 
truncated (amino acids 1-597) human DISC1 [DISC1(1-597)].   
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Behavioral alterations in transgenic flies expressing full-length DISC1 enriched in the nucleus 
To address phenotypic changes in DISC1 transgenic flies, we measured their activities by using 
the Drosophila Activity Monitor System (DAMS), which counts the number of infrared beam 
crossings by an individual fly placed in a small glass tube (Figure 2A).  Flies exhibit a typical 
circadian activity pattern with more frequent and longer rest at night than during daytime. 
Quantitative characteristics measured by this system are known to reflect their arousal and sleep 
homeostasis (25, 31, 34-38).  When DISC1-FL was induced in MBs, male, but not female, flies 
displayed reduced arousal state as evidenced by increased sleep time per day (Figure 2B, C).  
This sex-specific sleep change is observed only when DISC1-FL was induced, but not DISC1(1-
597) or control w(CS10) flies (Figure 2B, C).  In DISC1-FL flies, the average length of each 
sleep (sleep bout), but not its frequency during the day (number of sleep bouts), was increased 
(Figure 2D).  Nevertheless, the circadian cycle was not markedly changed in all types of flies 
(Figure 2B, C).  This sleep alteration is not due to the genetic background of the transgenic flies, 
because there was no alteration in sleep status in heterozygous control flies carrying UAS-DISC1 
or the GeneSwitch driver alone (Supplementary Figure 2).  Addition of RU486 did not affect 
sleep amount in control flies (w(CS10)) that have no transgene (Figure 2B).  The increased sleep 
amount was not a reflection of motor disturbance, because no change was observed in the walk 
speed upon induction of DISC1-FL (Figure 2E). 
     To address a molecular clue that accounts for this sleep-associated phenotypic change, we 
examined cellular distribution of induced DISC1 protein (Figure 2F).  Interestingly, DISC1-FL 
displayed unique punctate staining selectively in the nucleus, whereas DISC1(1-597) did not.  
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The punctate DISC1-FL was co-localized with a transcription factor Dachshund (DAC) in the 
nucleus (Figure 2G).  Expression levels of DISC1(1-597) was comparable or even higher than 
that of DISC1-FL, but the protein distribution was diffuse in both the cytoplasm and the nucleus 
of the cell bodies.  There was no sex difference in nuclear punctate staining of DISC1-FL 
(Supplementary Figure 3A).  These staining patterns of DISC1-FL and DISC1(1-597) were 
observed also in large neurosecretary cells located at the dorsomedial region of the fly brain 
(Supplementary Figure 3B).  No immunoreactivity of DISC1-FL and DISC1(1-597) was 
observed in the dendritic structures (calyx) and the extended axonal structures (lobes) in MBs 
(Supplementary Figure 3C).   Although localization of a pool of DISC1 in the nucleus has been 
reported in human brains, subnuclear distribution has not yet been characterized (9, 13).  
 
Nuclear DISC1 in mammalian cultured cells 
To characterize the nuclear distribution of DISC1 in greater detail, we examined the subcellular 
localization of DISC1 in primary cortical neurons by immunofluorescent staining.  DISC1 
immunoreactivity was observed in both the nucleus and the cytoplasm in both immature and 
mature neurons (Figure 3A).  In the nucleus of primary neurons, endogenous DISC1 was present 
in a punctate pattern, similar to that observed in fly tissues.  For further examination of the 
subnuclear localization of DISC1, we used HeLa cells as a model by expressing DISC1 
ectopically.  When cells were transfected by moderate dose of DNA (0.1-0.5 μg), DISC1 
displayed predominantly a punctate nuclear distribution (Supplementary Figure 4), similar to the 
expression pattern observed in fly brain as well as that in primary cortical neurons (Figures 2F 
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and 3A).  We investigated the subnuclear localization of DISC1, relative to nuclear speckles (the 
domains for pre-mRNA splicing), coiled bodies (the domains for snRNP biogenesis and 
trafficking), and promyelocytic leukemia (PML) bodies (the nuclear bodies for gene 
transcription).  DISC1 was found to be co-localized only with PML bodies (Figure 3B).  
 
Three cis-elements that regulate nuclear distribution of DISC1  
Because DISC1 exists in both the nucleus and the cytoplasm, we investigated the cis-elements 
that may regulate the nuclear localization of DISC1.  As previously reported (39, 40), DISC1 has 
two putative nuclear localization signals (NLSs) (Figure 4A).  First, we fused the corresponding 
NLS peptides with enhanced green fluorescent protein (eGFP) and examined the localization of 
the fused proteins.  As shown in Supplementary Figure 5A, the eGFP-NLS1 fusion protein had a 
punctate nuclear expression pattern, but the eGFP-NLS2 or the eGFP-mNLS1 that contains a 
mutated NLS1 did not, suggesting that NLS1 is a functional element.  To test the role of NLS1 in 
the context of full-length DISC1, we examined the subcellular distribution of DISC1 with 
deletion of NLS1 [DISC1(46-854)] or with a point mutation in the NLS1 sequences (Figure 4A).  
These mutants displayed cytoplasmic/perinuclear, but not nuclear, localization.  In flies, 
expression of DISC1-mNLS1 resulted in perinuclear localization in large neurosecretary cells 
and MB neurons (Supplementary Figure 3B, D).  Taken together, these results indicate that 
NLS1 is required for the nuclear localization of DISC1 in both mammalian cells and flies.   
     Systematic deletion of DISC1 from the C-terminus indicated that another cis-element on 
DISC1 was also required for nuclear localization.  Punctate nuclear distribution was still 
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observed in DISC1(1-671), but not in DISC1(1-597), suggesting that an element between 
residues 598 and 671 plays a necessary role in the proper localization of DISC1 (Figure 4B).  
Inspection of the sequences in this region revealed a leucine zipper domain (LZ) at around amino 
acid 610.  Mutation of two leucine residues in this region altered the distribution of DISC1 from 
the punctate nuclear pattern to the cytoplasmic localization (Figure 4B).  Thus, punctate nuclear 
expression of DISC1 required at least two cis-elements: NLS1 and LZ.  Of note, this LZ element 
includes a polymorphism at amino acid 607 that is associated with schizoaffective disorder (41).    
     Although DISC1(1-597) contains one functional NLS (NLS1), a large amount of this protein 
localized in the cytoplasm in a diffuse pattern (Figure 4C) as did in the Drosophila neurons 
(Figure 2F).  This suggests a possible motif in 1-597 of DISC1 that contributes to export of the 
protein out of the nucleus.  Treatment of HeLa cells expressing DISC1(1-597) with Leptomycin 
B, a potent inhibitor of CRM1/exportin-mediated export pathway (42), altered the localization of 
the protein to the nucleus, suggesting the existence of functional nuclear export signal(s) (NES) 
in the N-terminal region(1-597) (Supplementary Figure 5B).  There are three sequences that fit 
the loose consensus for NES (Figure 4C).  Expression of NES2 together with eGFP resulted in 
the localization of the GFP signal exclusively in the cytoplasm, in strong contrast to the 
ubiquitous GFP staining by eGFP-NES1, or eGFP-NES3, or eGFP alone (Supplementary Figure 
5C).  DISC1(1-597) with a mutation in NES2 (DISC1(1-597)-mNES2) exhibited only diffuse 
nuclear localization, in contrast to DISC1(1-597), suggesting that NES2 has a role to export 
DISC1 out of the nucleus (Figure 4C). 
     In all these experiments, we monitored the expression levels of the wild-type and mutant 
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proteins by immunoblot and found comparable levels of expression for all proteins (data not 
shown), excluding the possibility that the changes in their subcellular distributions were due to 
the changes in their expression levels.   
 
DISC1 binds to ATF4/CREB2 and N-CoR, and modulates CRE-mediated gene transcription 
DISC1 co-localizes with the PML bodies where various gene transcriptions are controlled, and 
has been known to bind to a transcription factor ATF4/CREB2, which is one of the ATF/CREB 
family transcription factors that belong to a group of basic region-leucine zipper (bZIP) proteins 
originally defined by their ability to bind the consensus ATF/CRE site “TGACGTCA” (43). 
ATF/CREB2 mediates/modulates gene transcription, and has been implicated in regulating brain 
functions, including a form of long-term memory (44-47).  Thus, we questioned whether DISC1 
could modulate ATF4/CREB2-mediated gene transcription.  We initially used a Gal4-based 
transcriptional assay.  A reporter construct containing Gal4-binding DNA promoter sequences 
upstream of a luciferase gene was co-transfected with an expression construct for a fusion 
protein of the Gal4 DNA binding domain (Gal4-DBD) and ATF4/CREB2.  Expression of Gal4-
ATF4/CREB induced robust transcriptional activation as indicated by the reporter assay (Figure 
5A).  Additional expression of DISC1 with Gal4-ATF4/CREB2 repressed the luciferase signal, 
suggesting that DISC1 may recruit transcriptional repressor(s) to ATF4-containing transcriptional 
machinery. We further characterized the interaction of DISC1 and ATF4/CREB2, and 
demonstrated their direct protein interaction by in vitro binding assays with purified recombinant 
GST-DISC1 and His-ATF4/CREB2 (Figure 5B).  Cellular interaction of human DISC1 and CRC 
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(cryptocephal), the fly orthologue of human ATF4/CREB2, was demonstrated by co-
immunoprecipitation (48) (Supplementary Figure 6).  Co-immunoprecipitation with several 
DISC1 deletion mutants indicated that the LZ domain in exon 9 is the minimum domain of 
DISC1 required for binding to ATF4/CREB2 (Figure 5C).  Consistent with our luciferase 
reporter assay, DISC1 binds with a transcriptional repressor N-CoR as indicated by co-
immunoprecipitation (Figure 5D).  The interaction was maintained even after the deletion of 
exon 9, or exons 9-11, or exon 13, but was abolished by the entire deletion from exon 9 to exon 
13.  These results suggest that the domain coded by exon 12 may have an important role in 
DISC1-N-CoR interaction.  There was no overlap in the binding domains of DISC1 for 
ATF4/CREB2 (the coding domain in exon 9) and N-CoR, suggesting that DISC1 may interact 
with both ATF4/CREB2 and N-CoR simultaneously.  These results suggest that, by recruiting N-
CoR to an ATF4/CREB2-containing complex as a common scaffold, DISC1 might modulate 
gene transcription regulated by ATF4/CREB2.   
     ATF4/CREB2 is known to repress CRE-dependent gene transcription when the cAMP-protein 
kinase A (PKA) signaling pathway is activated (49).  To test whether DISC1 modulates CRE-
mediated gene transcription, we used a CRE-driven luciferase reporter in the absence or presence 
of forskolin, an agent that increases intracellular cAMP levels and activates the PKA pathway.  
Consistent with the literature (49), forskolin treatment greatly increased the reporter activity 
driven by the CRE sites, and ectopic expression of ATF4/CREB2 repressed the forskolin-induced 
signal (Figure 5E).  Of interest, co-expression of DISC1 together with ATF4/CREB2 further 
decreased the reporter activity.  Selective deletion of LZ in DISC1, the domain responsible for 
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binding to ATF4/CREB2, abolished the effects, suggesting that interaction between 
ATF4/CREB2 and DISC1 is required for the augmented suppression by DISC1.  Of note, 
although nuclear levels of ATF4/CREB2 are reportedly increased upon the activation of cAMP-
PKA signaling (50), we did not observe changes in distribution and levels of nuclear DISC1 as a 
result of the addition of forskolin (data not shown).   
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Discussion  
There are two major findings in this report.  First, we generated transgenic flies expressing 
human DISC1.  In the flies, human full-length DISC1 is expressed in a punctate pattern in the 
nucleus.  DISC1 transgenic flies in adults display alterations in sleep homeostasis, suggesting a 
role for DISC1 in sleep regulation in vivo.  In flies, CREB signaling or CRE-mediated gene 
transcription has been reported to play an essential role in sleep homeostasis (21).  Second, we 
characterized nuclear DISC1 in mammalian cells.  Consistent with the nuclear punctate pattern in 
flies, a pool of DISC1 was localized in the nucleus in a punctate pattern in primary neuron 
cultures and HeLa cells.  DISC1 co-localized with PML, a main component of the nuclear body, 
a nuclear compartment for gene transcription.  DISC1 interacted with ATF4/CREB2 and N-CoR 
in distinct binding domains.  Consequently, DISC1 modulates CRE-mediated gene transcription 
in cell models. 
     Sleep is defined by periods of quiescence that are associated with reduced response to the 
external environment (51, 52).  Sleep is tightly regulated, and is under the control of both a 
circadian clock and homeostatic mechanisms (51, 52).  For the past decade, molecular 
mechanisms underlying the circadian clock have been substantially clarified (53), but 
mechanisms underlying sleep homeostasis remain to be elucidated.  Fruit flies (Drosophila 
melanogaster) are now being used as a powerful tool to elucidate regulatory mechanisms of 
sleep not only for circadian rhythms but also for sleep homeostasis (25, 34).  Pharmacological 
agents, such as caffeine and antihistamines, influence sleep in flies.  A recent study has further 
demonstrated that methamphetamine, a psychostimulant, could suppress sleep and promote 
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wakefulness in flies, whereas inhibitors of dopamine synthesis exhibited the opposite effects (54).  
Prolonged rest in flies is associated with higher arousal threshold and is homeostatically 
regulated independently of the circadian clock.  Moreover, cAMP-CREB signaling, which leads 
to CRE-mediated gene transcription, has been reported to play a role in sleep homeostasis in flies 
(21).   
     In the present study, in male flies we observed that exogenous expression of full-length 
DISC1, but not a C-terminal truncated DISC1 [DISC1(1-597)], altered sleep time, but not the 
frequency of sleep bouts, or the circadian rhythm.  Because full-length DISC1, but not the C-
terminal truncated DISC1 [DISC1(1-597)], is targeted to the punctate nuclear bodies, this 
specific targeting may be associated with the phenotypic difference between these flies.  Given 
the conservation of the fundamental mechanisms of sleep between flies and mammals, 
modulation of conserved endogenous nuclear factors, such as ATF/CREB family proteins, may 
possibly contribute to the phenotypes of flies.  Two approaches will be of considerable interest in 
the future: 1) systematic assays with flies with various types of DISC1 containing sequential 
deletions; 2) screening of genetic interactors that normalize or enhance the DISC1–induced sleep 
alteration.   
     To address molecular mechanisms that target DISC1 in the punctate nuclear structures, we 
identified three cis-acting elements that regulate the nuclear localization of DISC (NLS1, NES2, 
and LZ).  Mutation of either NLS1 or LZ leads to non-nuclear DISC1 staining in cells.  
Conceivably, each element plays a key role in nuclear or non-nuclear distribution of DISC1 by 
keeping subtle balances among these elements.  Although regulation of DISC1 localization has 
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been studied previously by domain mapping (8, 55), our report is the first to define the cis-
elements.  Porteous and colleagues (8) reported that a large deletion of the C-terminal region 
(598-854 amino acids), which contains the LZ identified in this study, dramatically augmented 
the cytoplasmic localization of DISC1 and that further deletion of the middle portion (359-597 
amino acids), which contains the NES2, augmented punctate DISC1 distribution in the nucleus.  
Brandon and colleagues (55) used GFP-tagged DISC1 constructs at a high dose (20 μg) and 
reported the importance of a central coiled-coil region in regulating the subcellular distribution 
of DISC1, especially its targeting to the mitochondria.  This region is independent of the cis-
domains for the nuclear targeting (NLS1, NES2, and LZ) reported in the study.  Fly models 
expressing mutant DISC1 selectively deficient in these cis-domains will pinpoint a nuclear role 
for DISC1 in sleep control in vivo.   One of such models, the fly expressing mNLS1, displayed 
non-nuclear DISC1 staining, supporting the notion that the mutant flies generated on the basis of 
data from mammalian cells will be potentially useful in future studies. 
     Our report suggests that DISC1 modulates CRE-mediated gene transcription by interacting 
with ATF4/CREB2.  Interaction of DISC1 with N-CoR may play a key role in this modulation, 
because N-CoR is responsible for recruiting histone deacetylase to targeted transcriptional 
machinery (56).  Recent studies have suggested a role for the cascades involving histone 
acetyltransferase and deacetylase in psychiatric conditions, including cocaine-induced plasticity, 
depression, and schizophrenia (57-59).  Because nuclear DISC1 is altered in brains from subjects 
with psychosis as well as those with substance or alcohol abuse (13), disturbance of DISC1 with 
respect to recruitment of the repressor complex to transcriptional machinery, such as that 
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comprising CREB and ATF4/CREB2, may play an important role in a wide range of psychiatric 
disorders.  Considering that sleep disturbance exists in almost all psychiatric conditions, a role 
for DISC1 in sleep homeostasis, at least as demonstrated in fly models would be of particular 
interest in mouse models in future studies (60-62).  It is also intriguing to examine genetic 
variations that can potentially affect interaction of DISC1 with ATF4/CREB2 or N-CoR, such as 
non-synonymous polymorphism Leu607Phe (41), in association with sleep characteristics in 
human subjects, including patients with various psychiatric diseases.   
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Figure legends 
Figure 1  Expression of DISC1 in transgenic flies in a tissue- and temporal-specific manner.  (A) 
The GAL4-GeneSwitch chimeric protein binds to a UAS-DNA sequence in the presence of 
RU486, which in turn induces gene transcription downstream of the UAS sequences.  Inducible 
expression of DISC1 selectively in the mushroom bodies (MBs) is achieved by using an MB-
GeneSwitch construct, in which an MB-specific enhancer is linked to the coding region of 
GAL4-GeneSwitch.  (B, C) Confocal images of adult fly brains expressing the mCD8::GFP 
protein under control of the MB-GeneSwitch.  In the presence of RU486 (B, 0 µM; C, 250 µM), 
selective expression of the protein is observed in MBs.    
 
Figure 2  (A) Schematic illustration of activity monitoring system of flies.  (B) Daily activity 
patterns of flies expressing DISC1-FL or DISC1(1-597) under control of the MB-GeneSwitch.  
Activities were measured with (+RU486, black line) or without RU486 (-RU486, gray line).  
Sleep was defined as a continuous rest state longer than 5 min.  The results represent the average 
of three independent experiments.  Of note, the normal circadian activity patterns are not altered 
by DISC1 expression.  (C) Total amount of sleep per day (24 h).  Expression of DISC1-FL, but 
not DISC1(1-597) leads to significantly longer sleep in males.  Black bar, +RU486.  White bar, -
RU486.  Total number of flies used in each group is shown in the bar.  (D) Expression of DISC1-
FL increases the duration, but not the number, of sleep bouts in males.  Total number of flies 
used in each group is shown in the bar.  (E) Walking speed of DISC1-FL flies assayed by the 
Dynamic Image Analysis System.  Induction of DSC1-FL did not affect the walk speed in both 
sexes.  Black bar, +RU486.  White bar, -RU486.  (F) Localization of DICS1-FL and DISC1(1-
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597) in MB neurons.  DISC1-FL exhibited punctate nuclear localization, whereas DISC1(1-597) 
localized diffusely both in the nuclei and cytoplasm.  DISC1 and mCD8::GFP expression were 
driven by OK107, a MB-Gal4 driver.  Scale bar, 10 µm.  (G) Co-localization of DISC1 and DAC, 
a nuclear transcription factor, in MB neurons.  Red, DISC1; green, DAC, blue: TO-PRO3.  
Arrowheads indicate co-localized DISC1 and DAC.  DISC1 expression was driven by OK107.  
Scale bar, 5 μm. 
 
Figure 3  Nuclear DISC1 in mammalian cells.  (A) Immunofluorescent staining of primary 
neurons indicates that DISC1 occurs not only in the cytoplasm but also in the nucleus in a dotted 
pattern.  (B) Exogenous expression of DISC1 at a low dose in HeLa cells depicts the nuclear 
pool of DISC1.  A pool of DISC1 is co-localized with PML (white arrows), the main component 
of the nuclear body.  Red, exogenous DISC1 selectively detected by a HA-antibody; green, each 
nuclear marker (coilin for coiled bodies; PML for PML/nuclear bodies; SC35 for speckle).   
 
Figure 4  Functional cis-elements for nuclear distribution of DISC1.  (A) N-terminal deletion of 
DISC1 (amino acids 1-45) abolishes NLS1, leading to the distribution of DISC1 mainly in the 
cytoplasm.  Mutant DISC1 with amino acid substitutions in NLS1 (DISC1-mNLS1) occurs 
outside the nucleus, with enrichment at the perinuclear regions.  (B) Sequential C-terminal 
deletion of DISC1 indicates that there is a critical domain between 598 and 671 amino acids that 
determines the nuclear localization of DISC1.  DISC1-FL, DISC1(1-801), DISC1(1-748), 
DISC1(1-726), and DISC1(1-671) occur in the nucleus, but DISC1(1-597) does not.  
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Introduction of mutations in the LZ domain (DISC1-mLZ) alters the distribution of DISC1 from 
the nucleus to the cytoplasm.  (C) Introduction of mutations in NES2 leads to distribution of 
DISC(1-597) from cytoplasmic to a nuclear localization, suggesting that NES2 is functional.   
 
Figure 5  DISC1 binds to ATF4/CREB2 and N-CoR, and modulates CRE-mediated gene 
transcription.  (A) Exogenous expression of DISC1 suppresses Gal4-ATF4/CREB2-mediated 
transcription.  (B) Interaction of DISC1 and ATF4/CREB2 demonstrated by in vitro binding 
experiments with purified recombinant His-ATF4/CREB2 and GST-DISC1 proteins.  (C) 
Requirement of the LZ domain of DISC1 for protein interaction of DISC1 and ATF4/CREB2 as 
demonstrated by co-immunoprecipitation of ATF4/CREB2 and several types of DISC1 deletion 
mutants with an HA-tag in HeLa cells.  An anti-ATF4/CREB2 antibody was used for 
immunoprecipitation, and an anti-HA antibody for detection.  (D) Importance of exon 12 of 
DISC1 for interaction of DISC1 and N-CoR is indicated by co-immunoprecipitation.  An anti-N-
CoR antibody is used for precipitation, and an anti-HA antibody for detection of 
immunoprecipitates by Western blotting.  (E) Exogenous expression of DISC1, but not mutant 
DISC1 with deletion of LZ, augments ATF4/CREB2-mediated repression of CRE-dependent 
gene transcription.  
 






